S100B

S100B

S100B 분자 정보

Molecule Name
Protein Nef
분자 별명
S100B,NEF,S100,S100beta
Drug Development Progress
임상 약물 수1
시판 약물 수0
최고 연구 개발 단계Phase 1 Clinical
표적 별명
nef,Negative factor,3'ORF,Protein Nef,F-protein
분자 배경
S-100 protein beta chain (S100B),a member of the S-100 family, is also known as S-100 protein subunit beta and S100 calcium-binding protein B, which contains two EF-hand domains. S100B can weakly bind calcium but bind zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Also, S100B can bind to and initiate the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction,S100B may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Fuethermore,S100B could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization. S100B may mediate calcium-dependent regulation on many physiological processes by interacting with other proteins, such as TPR-containing proteins, and modulating their activity.

S100B 제품 목록

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • E. coli(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
S100B
Human S100B Protein, His Tag
Human
E. coli
SDS-PAGE

$260.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)Phase 1 ClinicalImmunomic Therapeutics Inc
HIV Infections
상세
Customer Reviews